Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

45.57
Delayed Data
As of Dec 09
 -0.99 / -2.13%
Today’s Change
19.59
Today|||52-Week Range
62.68
-26.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.5B

Company Description

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery. It operates its business through the Ionis Core and Akea Therapeutics segments. The Ionis Core segment involves a a novel drug discovery platform generate a broad pipeline of drugs. The Akea Therapeutics segment develops and commercializes drugs for cardiometabolic disorders. The company was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Contact Information

Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2331

Employees

Shareholders

Mutual fund holders53.72%
Other institutional36.23%
Individual stakeholders0.78%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
B. Lynne ParshallChief Operating Officer & Director
Elizabeth L. HougenChief Financial Officer & Senior VP-Finance
C. Frank BennettSenior Vice President-Antisense Research
Brett P. MoniaSenior VP-Drug Discovery & Corporate Development